tiprankstipranks
Trending News
More News >
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
US Market

Ionis Pharmaceuticals (IONS) Stock Forecast & Price Target

Compare
1,353 Followers
See the Price Targets and Ratings of:

IONS Analyst Ratings

Moderate Buy
20Ratings
12 Buy
8 Hold
0 Sell
Based on 20 analysts giving stock ratings to
Ionis
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IONS Stock 12 Month Forecast

Average Price Target

$55.37
▲(64.99% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Ionis Pharmaceuticals in the last 3 months. The average price target is $55.37 with a high forecast of $78.00 and a low forecast of $38.00. The average price target represents a 64.99% change from the last price of $33.56.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"$26","79":"$79","39.25":"$39.3","52.5":"$52.5","65.75":"$65.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":78,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$78.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":55.37,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$55.37</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$38.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[26,39.25,52.5,65.75,79],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.71,35.27076923076923,38.831538461538464,42.392307692307696,45.95307692307692,49.51384615384616,53.074615384615385,56.635384615384616,60.19615384615385,63.75692307692308,67.31769230769231,70.87846153846155,74.43923076923076,{"y":78,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.71,33.53,35.35,37.17,38.99,40.81,42.629999999999995,44.45,46.269999999999996,48.09,49.91,51.730000000000004,53.55,{"y":55.37,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,31.71,32.19384615384615,32.67769230769231,33.16153846153846,33.645384615384614,34.12923076923077,34.613076923076925,35.096923076923076,35.58076923076923,36.06461538461539,36.54846153846154,37.03230769230769,37.51615384615385,{"y":38,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":43.01,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.57,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.11,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.32,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.68,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.07,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.76,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.1,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.9,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.19,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.26,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.71,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$78.00Average Price Target$55.37Lowest Price Target$38.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guggenheim
$65$64
Buy
90.70%
Upside
Reiterated
05/01/25
Barclays Analyst forecast on IONS
Gena WangBarclays
Barclays
$51
Hold
51.97%
Upside
Reiterated
05/01/25
Oppenheimer Analyst forecast on IONS
Jay OlsonOppenheimer
Oppenheimer
$78
Buy
132.42%
Upside
Reiterated
05/01/25
Stifel Nicolaus Analyst forecast on IONS
Paul MatteisStifel Nicolaus
Stifel Nicolaus
$38
Hold
13.23%
Upside
Reiterated
05/01/25
BMO Capital Analyst forecast on IONS
Kostas BiliourisBMO Capital
BMO Capital
$45$40
Hold
19.19%
Upside
Reiterated
05/01/25
H.C. Wainwright Analyst forecast on IONS
Mitchell KapoorH.C. Wainwright
H.C. Wainwright
$45$50
Buy
48.99%
Upside
Reiterated
05/01/25
TD Cowen Analyst forecast on IONS
Yaron WerberTD Cowen
TD Cowen
$59
Buy
75.80%
Upside
Reiterated
04/30/25
Bank of America Securities Analyst forecast on IONS
Jason GerberryBank of America Securities
Bank of America Securities
$63
Buy
87.72%
Upside
Reiterated
04/30/25
William Blair Analyst forecast on IONS
Myles MinterWilliam Blair
William Blair
Buy
Reiterated
04/30/25
Wells Fargo Analyst forecast on IONS
Yanan ZhuWells Fargo
Wells Fargo
$77
Buy
129.44%
Upside
Reiterated
04/30/25
Needham
$60$55
Buy
63.89%
Upside
Reiterated
04/30/25
Leerink Partners Analyst forecast on IONS
Mani ForooharLeerink Partners
Leerink Partners
$55$59
Buy
75.80%
Upside
Reiterated
04/30/25
RBC Capital Analyst forecast on IONS
Luca IssiRBC Capital
RBC Capital
$70
Buy
108.58%
Upside
Reiterated
04/30/25
Morgan Stanley Analyst forecast on IONS
Michael UlzMorgan Stanley
Morgan Stanley
$55$52
Hold
54.95%
Upside
Reiterated
04/11/25
Citi
$64
Buy
90.70%
Upside
Reiterated
04/03/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guggenheim
$65$64
Buy
90.70%
Upside
Reiterated
05/01/25
Barclays Analyst forecast on IONS
Gena WangBarclays
Barclays
$51
Hold
51.97%
Upside
Reiterated
05/01/25
Oppenheimer Analyst forecast on IONS
Jay OlsonOppenheimer
Oppenheimer
$78
Buy
132.42%
Upside
Reiterated
05/01/25
Stifel Nicolaus Analyst forecast on IONS
Paul MatteisStifel Nicolaus
Stifel Nicolaus
$38
Hold
13.23%
Upside
Reiterated
05/01/25
BMO Capital Analyst forecast on IONS
Kostas BiliourisBMO Capital
BMO Capital
$45$40
Hold
19.19%
Upside
Reiterated
05/01/25
H.C. Wainwright Analyst forecast on IONS
Mitchell KapoorH.C. Wainwright
H.C. Wainwright
$45$50
Buy
48.99%
Upside
Reiterated
05/01/25
TD Cowen Analyst forecast on IONS
Yaron WerberTD Cowen
TD Cowen
$59
Buy
75.80%
Upside
Reiterated
04/30/25
Bank of America Securities Analyst forecast on IONS
Jason GerberryBank of America Securities
Bank of America Securities
$63
Buy
87.72%
Upside
Reiterated
04/30/25
William Blair Analyst forecast on IONS
Myles MinterWilliam Blair
William Blair
Buy
Reiterated
04/30/25
Wells Fargo Analyst forecast on IONS
Yanan ZhuWells Fargo
Wells Fargo
$77
Buy
129.44%
Upside
Reiterated
04/30/25
Needham
$60$55
Buy
63.89%
Upside
Reiterated
04/30/25
Leerink Partners Analyst forecast on IONS
Mani ForooharLeerink Partners
Leerink Partners
$55$59
Buy
75.80%
Upside
Reiterated
04/30/25
RBC Capital Analyst forecast on IONS
Luca IssiRBC Capital
RBC Capital
$70
Buy
108.58%
Upside
Reiterated
04/30/25
Morgan Stanley Analyst forecast on IONS
Michael UlzMorgan Stanley
Morgan Stanley
$55$52
Hold
54.95%
Upside
Reiterated
04/11/25
Citi
$64
Buy
90.70%
Upside
Reiterated
04/03/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ionis Pharmaceuticals

Which Analyst Should I Follow If I Want to Buy IONS and Sell After:
1 Month
xxx
Success Rate
11/17 ratings generated profit
65%
Average Return
+1.91%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.71% of your transactions generating a profit, with an average return of +1.91% per trade.
3 Months
xxx
Success Rate
17/31 ratings generated profit
55%
Average Return
+1.60%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 54.84% of your transactions generating a profit, with an average return of +1.60% per trade.
1 Year
Gary NachmanRaymond James
Success Rate
11/17 ratings generated profit
65%
Average Return
+13.86%
reiterated a buy rating 3 months ago
Copying Gary Nachman's trades and holding each position for 1 Year would result in 64.71% of your transactions generating a profit, with an average return of +13.86% per trade.
2 Years
xxx
Success Rate
11/17 ratings generated profit
65%
Average Return
+17.36%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 64.71% of your transactions generating a profit, with an average return of +17.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IONS Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
19
21
14
26
21
Buy
2
1
2
3
3
Hold
8
9
12
10
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
29
31
28
39
32
In the current month, IONS has received 24 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. IONS average Analyst price target in the past 3 months is 55.37.
Each month's total comprises the sum of three months' worth of ratings.

IONS Financial Forecast

IONS Earnings Forecast

Next quarter’s earnings estimate for IONS is -$0.42 with a range of -$1.17 to $0.43. The previous quarter’s EPS was -$0.93. IONS beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.28% of the time in the same period. In the last calendar year IONS has Outperformed its overall industry.
Next quarter’s earnings estimate for IONS is -$0.42 with a range of -$1.17 to $0.43. The previous quarter’s EPS was -$0.93. IONS beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.28% of the time in the same period. In the last calendar year IONS has Outperformed its overall industry.

IONS Sales Forecast

Next quarter’s sales forecast for IONS is $248.50M with a range of $127.61M to $393.70M. The previous quarter’s sales results were $131.61M. IONS beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year IONS has Outperformed its overall industry.
Next quarter’s sales forecast for IONS is $248.50M with a range of $127.61M to $393.70M. The previous quarter’s sales results were $131.61M. IONS beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year IONS has Outperformed its overall industry.

IONS Stock Forecast FAQ

What is IONS’s average 12-month price target, according to analysts?
Based on analyst ratings, Ionis Pharmaceuticals’s 12-month average price target is 55.37.
    What is IONS’s upside potential, based on the analysts’ average price target?
    Ionis Pharmaceuticals has 64.99% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is IONS a Buy, Sell or Hold?
          Ionis Pharmaceuticals has a consensus rating of Moderate Buy which is based on 12 buy ratings, 8 hold ratings and 0 sell ratings.
            What is Ionis Pharmaceuticals’s price target?
            The average price target for Ionis Pharmaceuticals is 55.37. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $78.00 ,the lowest forecast is $38.00. The average price target represents 64.99% Increase from the current price of $33.56.
              What do analysts say about Ionis Pharmaceuticals?
              Ionis Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.
                How can I buy shares of IONS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis